Notably, the MARCHF6-mediated degradation of SREBP2 does not occur in tumor-infiltrating myeloid cells, in which hypoxia instead promotes SREBP2 processing by promoting Golgi–endoplasmic reticulum fusion (Nakahara et al., 2023). This evidence concerns the gene SREBF2 and neoplasm.